Sebastiao C, Pingarilho M, Bathy J, Bonfim E, Toancha K, Miranda M
BMC Infect Dis. 2024; 24(1):884.
PMID: 39210296
PMC: 11360575.
DOI: 10.1186/s12879-024-09803-1.
Owusu L, Ababio C, Boahene S, Zakaria A, Emikpe A, Dwumfour C
BMC Public Health. 2023; 23(1):1113.
PMID: 37296400
PMC: 10257285.
DOI: 10.1186/s12889-023-16032-9.
Kimaina A, Dick J, DeLong A, Chrysanthopoulou S, Kantor R, Hogan J
Stat Commun Infect Dis. 2023; 12(Suppl1):20190017.
PMID: 37288469
PMC: 10243177.
DOI: 10.1515/scid-2019-0017.
Olanrewaju A, Sullivan B, Zhang J, Bender A, Sevenler D, Lo T
ACS Sens. 2020; 5(4):952-959.
PMID: 32248685
PMC: 7183420.
DOI: 10.1021/acssensors.9b02198.
Desta A, Woldearegay T, Futwi N, Gebrehiwot G, Gebru G, Berhe A
BMC Infect Dis. 2020; 20(1):4.
PMID: 31898535
PMC: 6941313.
DOI: 10.1186/s12879-019-4732-6.
Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
Desta A, Woldearegay T, Berhe A, Futwi N, Gebru G, Godefay H
PLoS One. 2019; 14(12):e0226293.
PMID: 31830095
PMC: 6907779.
DOI: 10.1371/journal.pone.0226293.
Accurate dried blood spots collection in the community using non-medically trained personnel could support scaling up routine viral load testing in resource limited settings.
Sikombe K, Hantuba C, Musukuma K, Sharma A, Padian N, Holmes C
PLoS One. 2019; 14(10):e0223573.
PMID: 31622394
PMC: 6797100.
DOI: 10.1371/journal.pone.0223573.
Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.
Budayanti N, Merati T, Bela B, Mahardika G
Curr HIV Res. 2019; 16(5):374-382.
PMID: 30714528
PMC: 6446452.
DOI: 10.2174/1570162X17666190204101154.
Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.
Chimukangara B, Kharsany A, Lessells R, Naidoo K, Rhee S, Manasa J
AIDS Res Hum Retroviruses. 2018; 35(2):129-138.
PMID: 30430843
PMC: 6360398.
DOI: 10.1089/AID.2018.0202.
HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
Arimide D, Abebe A, Kebede Y, Adugna F, Tilahun T, Kassa D
PLoS One. 2018; 13(10):e0205446.
PMID: 30304061
PMC: 6179264.
DOI: 10.1371/journal.pone.0205446.
Implementation of a point mutation assay for HIV drug resistance testing in Kenya.
Duarte H, Beck I, Levine M, Kiptinness C, Kingoo J, Chohan B
AIDS. 2018; 32(16):2301-2308.
PMID: 30005020
PMC: 6170675.
DOI: 10.1097/QAD.0000000000001934.
spp. From Ethiopia Producing Antimicrobial Compounds: Characterization via Bioassays, Genome Analyses, and Mass Spectrometry.
Kibret M, Guerrero-Garzon J, Urban E, Zehl M, Wronski V, Ruckert C
Front Microbiol. 2018; 9:1270.
PMID: 29946312
PMC: 6007079.
DOI: 10.3389/fmicb.2018.01270.
Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.
Vandormael A, Boulware D, Tanser F, Barnighausen T, Stott K, de Oliveira T
J Acquir Immune Defic Syndr. 2015; 71(4):462-6.
PMID: 26484740
PMC: 4767659.
DOI: 10.1097/QAI.0000000000000870.
Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial.
Kamwesiga J, Mutabazi V, Kayumba J, Tayari J, Uwimbabazi J, Batanage G
AIDS. 2015; 29(9):1045-52.
PMID: 25870994
PMC: 4444428.
DOI: 10.1097/QAD.0000000000000673.
Substandard/counterfeit antimicrobial drugs.
Kelesidis T, Falagas M
Clin Microbiol Rev. 2015; 28(2):443-64.
PMID: 25788516
PMC: 4402958.
DOI: 10.1128/CMR.00072-14.
HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
Kantor R, DeLong A, Balamane M, Schreier L, Lloyd Jr R, Injera W
J Int AIDS Soc. 2014; 17:19262.
PMID: 25413893
PMC: 4238965.
DOI: 10.7448/IAS.17.1.19262.
Optimal starting point for antiretroviral HIV treatment in a town in Cameroon: a randomised controlled study.
Holtedahl K, Salpou D, Braaten T, Berved Z
BMC Public Health. 2014; 14:828.
PMID: 25108448
PMC: 4138380.
DOI: 10.1186/1471-2458-14-828.
Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.
Lessells R, Stott K, Manasa J, Naidu K, Skingsley A, Rossouw T
BMC Health Serv Res. 2014; 14:116.
PMID: 24606875
PMC: 3973961.
DOI: 10.1186/1472-6963-14-116.
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques.
Hsu M, Keele B, Aravantinou M, Krawczyk N, Seidor S, Abraham C
PLoS One. 2014; 9(2):e89300.
PMID: 24586674
PMC: 3937329.
DOI: 10.1371/journal.pone.0089300.
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
Monleau M, Aghokeng A, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N
J Clin Microbiol. 2014; 52(2):578-86.
PMID: 24478491
PMC: 3911301.
DOI: 10.1128/JCM.02860-13.
